NOVEL CONCOMITANT USE OF SULFONAMIDE COMPOUND WITH ANTI-CANCER AGENT
摘要
<p>The invention relates to a pharmaceutical composition and a kit characterized by comprising a sulfonamide compound and a platinum complex compound, a DNA-topoisomerase I inhibitor, a metabolic antagonist, a microtubule inhibitor or an antibiotic in combination and a method of treating cancer and/or a method of inhibiting angiogenesis.</p>
